Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts
Background: Metastatic breast cancer (MBC) is currently an incurable condition that is primarily treated with palliative measures. Isolation of circulating tumor cells (CTCs) from the peripheral blood of these patients provides a predictive prognostic indicator, independent of the type of therapy, s...
Main Authors: | Abd Hamid, U.M (Author), Cristofanilli, M. (Author), Reuben, J.M (Author), Rudd, P.M (Author), Saldova, R. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2011
|
Subjects: | |
Online Access: | View Fulltext in Publisher View in Scopus |
Similar Items
-
Regulation of T Cell Trafficking by Enzymatic Synthesis of O-Glycans
by: Samuel J. Hobbs, et al.
Published: (2017-05-01) -
Synthèse d'oligosaccharides pour applications biologiques : aminoéthyle glycoside de sialyl Lewis X et glycosyl-carbasucres
by: Lu, Dan
Published: (2014) -
Natural and Synthetic Sialylated Glycan Microarrays and Their Applications
by: Alyssa M. McQuillan, et al.
Published: (2019-09-01) -
Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients
by: Abd Hamid, U.M, et al. -
Conditioned Medium from Malignant Breast Cancer Cells Induces an EMT-Like Phenotype and an Altered N-Glycan Profile in Normal Epithelial MCF10A Cells
by: Jia Guo, et al.
Published: (2017-08-01)